特集／臨床試験とバイオマーカー
２．がん分子標的治療のバイオマーカー
2010 年 41 巻 3 号 p. 95-100
詳細
2010 年 41 巻 3 号 p. 95-100
Molecular target therapy constitutes an essential component of standard cancer therapy of the 21st century. Hence the importance of biomarkers and their research are growing. Biomarkers are used for risk assessment, early detection, prediction of prognosis and surrogate endpoints. Biomarkers are also essential for the development of personalized medicine. Many biomarkers are biological substances related to normal tissues including the stroma, vessels as well as tumor tissues. Omics technology is also being used worldwide.
